Medication info
Exosium Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Exosium Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.25mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-Alu×2], 28 tablets/box [7 tablets/Alu-Alu×4]
Approval status
Active

MFDS item code 202007779 · Approved 2020.11.12 · Insurance code 642803310

Summary

Main use
Treatment of acid-related disorders (such as reflux disease), Helicobacter pylori eradication, and gastrointestinal disorders associated with anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
This product should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 20mg once daily 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Once symptoms have resolved, subsequent symptoms may be controlled by administering 20mg once daily. In adults, 20mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Administer this product 20mg in combination with amoxicillin 1g and clarithromycin 500mg twice daily for 7 days. 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials exceeding 4 weeks have not been conducted. 20mg once daily. The treatment duration is 4∼8 weeks. 20mg once daily The recommended initial dose is 40mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should be continued while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80∼160mg per day. Doses exceeding 80mg per day should be divided into 2 doses. Administer 40mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this product should not exceed 20mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent symptoms may be controlled by administering 20mg once daily. Children under 12 years of age: There is no experience with administration of this product to children under 12 years of age.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as reflux disease), Helicobacter pylori eradication, and gastrointestinal disorders associated with anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers.
View approved original text

This medicine is effective for the treatment of gastroesophageal reflux disease, especially erosive esophagitis, and for long-term maintenance therapy to prevent recurrence of esophagitis. It is also used in combination therapy with antibiotics for the treatment of peptic ulcers and duodenal ulcers caused by Helicobacter pylori infection. It helps treat gastrointestinal symptoms and gastric ulcers that may arise due to non-steroidal anti-inflammatory drug use. It is also used in the treatment of Zollinger-Ellison syndrome and for maintenance therapy after preventing rebleeding from gastric and duodenal ulcers. Overall, it is very effective in maintaining the health of the stomach and esophagus and in treating and preventing recurrence of gastrointestinal diseases.

Dosage and Administration

Adult dosage

This product should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 20mg once daily 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Once symptoms have resolved, subsequent symptoms may be controlled by administering 20mg once daily. In adults, 20mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Administer this product 20mg in combination with amoxicillin 1g and clarithromycin 500mg twice daily for 7 days. 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials exceeding 4 weeks have not been conducted. 20mg once daily. The treatment duration is 4∼8 weeks. 20mg once daily The recommended initial dose is 40mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should be continued while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80∼160mg per day. Doses exceeding 80mg per day should be divided into 2 doses. Administer 40mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this product should not exceed 20mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent symptoms may be controlled by administering 20mg once daily. Children under 12 years of age: There is no experience with administration of this product to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. First, patients who are allergic to this drug or its ingredients or have experienced hypersensitivity reactions should not use it. Patients currently taking certain antibiotics or some heart-related medications, breastfeeding women, and patients with a history of myocardial infarction should also refrain from taking this medication. This medication contains a dye called Yellow 5, so patients with allergies or a history of hypersensitivity to this component should use it with caution. Caution is necessary when taking this medication as various adverse reactions may occur. For example, reported reactions include blood-related issues, allergic reactions, electrolyte imbalances, headaches, dizziness, gastrointestinal symptoms, liver function abnormalities, skin rashes, muscle pain, etc. Especially, if symptoms such as muscle pain or weakness occur, it may be a serious condition called rhabdomyolysis, so immediate consultation with a physician is required. This drug can mask symptoms of malignant tumors during long-term use, so patients experiencing symptoms such as weight loss, vomiting, or hematemesis must notify their doctor. Furthermore, regular exams are necessary for those using this medication for over a year and it is important to consult a physician whenever symptoms change. This medication reduces stomach acid and can increase bacterial growth in the gastrointestinal tract, so patients should inform their doctor if diarrhea persists. Long-term use at high doses may increase the risk of fractures, so caution is needed for patients at risk of osteoporosis. Additionally, this medication may lower blood magnesium levels, so regular monitoring of magnesium levels is necessary for long-term use or when combined with certain drugs. This medication interacts with many other medications, requiring dose adjustments or caution depending on the co-administered drugs. Specifically, patients should consult their doctor or pharmacist if taking anticoagulants, anticonvulsants, certain antibiotics, antivirals, or immunosuppressants. The safety of this medication during pregnancy has not been fully established, so pregnant women should use it cautiously, and breastfeeding women are advised not to take this medication. In case of overdose, as there are no specific antidotes, appropriate treatment should be administered based on symptoms, and it is important to keep this medication out of reach of children. Lastly, transferring this medication to another container can alter its quality, so it should be stored in its original packaging.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorders, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, jaundice, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, polymorphous erythema, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial swelling, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, arthritis exacerbation, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, exacerbated depression, muscular hypertonicity, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbated migraine, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, micturition frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-Alu×2], 28 tablets/box [7 tablets/Alu-Alu×4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.